We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Stellar Pharmaceuticals Receives 2nd Uracyst(R) Patent in United States of America

News   Jan 27, 2012

 
Stellar Pharmaceuticals Receives 2nd Uracyst(R) Patent in United States of America
 
 
 

RELATED ARTICLES

The "Secret Weapon" of Virus-Neutralizing Antibodies

News

A new study in mice has explored why certain antibodies are highly effective in protecting the body against debilitating viruses like chikungunya.

READ MORE

Two HPV Types Linked to Cervical Cancer Have Declined Since Arrival of the HPV Vaccine

News

An analysis of cervical precancers over a period of seven years showed that two strains of human papillomavirus (HPV) that have been targeted by vaccination since 2006 have declined, accounting for a smaller proportion of cervical disease, according to newly published research.

READ MORE

Paradigm Shift for Design of Universal Vaccines

News

Killer T cells have been identified that can fight all influenza viruses – A, B and C – creating the potential for the development of a world-first universal, one-shot flu vaccine.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE